Clinically, GLP-1 RAs were initially approved for type 2 diabetes mellitus (T2DM) management, demonstrating durable glycemic control and cardiovascular risk reduction in trials ( [3] )
Sockalingam S, Leung SE, Hawa R, Wnuk S, Parikh SV, Jackson T, et al
The dataset used in this study was extensive, encompassing various aspects of patient information including demographic details, diagnoses (according to International Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM] codes), procedures (classified according to the International Classification of Diseases, Tenth Revision, Procedure Coding System [ICD-10-PCS] or Current Procedural Terminology), and medications (coded as per the Veterans Affairs National Formulary)
x axis is the surface area buried by receptor
Patience is not optional here
2C) revealed a significant increase in cardiomyocyte cross-sectional area in the PAB group compared to the Sham group, reflecting RV hypertrophy